Skip to main content
. Author manuscript; available in PMC: 2020 Sep 19.
Published in final edited form as: Anesth Analg. 2020 Sep;131(3):876–884. doi: 10.1213/ANE.0000000000004509

Figure 2.

Figure 2.

CMAX of MS. Comparison of mean (±SD) CMAX for plasma morphine during 540 minutes of blood sampling time between normal-weight, non-OSAS controls, nonobese OSAS, and obese patients with OSAS. Dose-adjusted mean CMAX in obese patients with OSAS is also presented. *P < .05 versus the nonobese/non-OSAS control group. CMAX indicates maximum concentration; MS, morphine sulfate; OSAS, obstructive sleep apnea syndrome; SD, standard deviation.